These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 29307692)

  • 1. Everolimus-eluting bioresorbable vascular scaffold implantation in Kawasaki disease: serial OCT observation.
    Vogiatzi G; Toutouzas K; Karanasos A; Synetos A; Latsios G; Tsiamis E; Tousoulis D
    Hellenic J Cardiol; 2018; 59(6):358-359. PubMed ID: 29307692
    [No Abstract]   [Full Text] [Related]  

  • 2. Coronary Artery Aneurysm After Bioresorbable Vascular Scaffold Implantation With Post-Dilation: Is Less More?
    Meincke F; Reinholz C; Spangenberg T; Wienemann H; Arjomand A; Kreidel F; Kuck KH; Ghanem A
    JACC Cardiovasc Interv; 2017 Jan; 10(1):96-97. PubMed ID: 28017314
    [No Abstract]   [Full Text] [Related]  

  • 3. Bioresorbable Vascular Scaffold Implantation for Successful Treatment of a Symptomatic Coronary Lesion in a 17-Year-Old Boy After Kawasaki Disease.
    Luu B; Esmaeili A; Schranz D; Fichtlscherer S
    Pediatr Cardiol; 2015 Oct; 36(7):1539-41. PubMed ID: 26063383
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of the second generation of a bioresorbable everolimus drug-eluting vascular scaffold for treatment of de novo coronary artery stenosis: six-month clinical and imaging outcomes.
    Serruys PW; Onuma Y; Ormiston JA; de Bruyne B; Regar E; Dudek D; Thuesen L; Smits PC; Chevalier B; McClean D; Koolen J; Windecker S; Whitbourn R; Meredith I; Dorange C; Veldhof S; Miquel-Hebert K; Rapoza R; García-García HM
    Circulation; 2010 Nov; 122(22):2301-12. PubMed ID: 21098436
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Paclitaxel crystals on the surface of a bioresorbable vascular scaffold visualized by optical coherence tomography after drug-eluting balloon angioplasty.
    López-Benito M; Pérez de Prado A; Cuellas C; Estévez R; Fernández-Vázquez F
    Eur Heart J Cardiovasc Imaging; 2017 Jun; 18(6):638. PubMed ID: 28329070
    [No Abstract]   [Full Text] [Related]  

  • 6. Predictors of acute scaffold recoil after implantation of the everolimus-eluting bioresorbable scaffold: an optical coherence tomography assessment in native coronary arteries.
    Sato T; Jose J; El-Mawardy M; Sulimov DS; Tölg R; Richardt G; Abdel-Wahab M
    Int J Cardiovasc Imaging; 2017 Feb; 33(2):145-152. PubMed ID: 27761749
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 'Full-plastic jacket' with bioresorbable vascular scaffolds: 5-year optical coherence tomography follow-up.
    Nai Fovino L; Barioli A; Tarantini G
    Eur Heart J Cardiovasc Imaging; 2019 Mar; 20(3):370. PubMed ID: 30561565
    [No Abstract]   [Full Text] [Related]  

  • 8. Incidence and imaging outcomes of acute scaffold disruption and late structural discontinuity after implantation of the absorb Everolimus-Eluting fully bioresorbable vascular scaffold: optical coherence tomography assessment in the ABSORB cohort B Trial (A Clinical Evaluation of the Bioabsorbable Everolimus Eluting Coronary Stent System in the Treatment of Patients With De Novo Native Coronary Artery Lesions).
    Onuma Y; Serruys PW; Muramatsu T; Nakatani S; van Geuns RJ; de Bruyne B; Dudek D; Christiansen E; Smits PC; Chevalier B; McClean D; Koolen J; Windecker S; Whitbourn R; Meredith I; Garcia-Garcia HM; Veldhof S; Rapoza R; Ormiston JA
    JACC Cardiovasc Interv; 2014 Dec; 7(12):1400-11. PubMed ID: 25523532
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Outcomes of everolimus-eluting stent incomplete stent apposition: a serial optical coherence tomography analysis.
    Shimamura K; Kubo T; Akasaka T; Kozuma K; Kimura K; Kawamura M; Sumiyoshi T; Ino Y; Yoshiyama M; Sonoda S; Igarashi K; Miyazawa A; Uzui H; Sakanoue Y; Shinke T; Morino Y; Tanabe K; Kadota K; Kimura T
    Eur Heart J Cardiovasc Imaging; 2015 Jan; 16(1):23-8. PubMed ID: 25342855
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fate of post-procedural malapposition of everolimus-eluting polymeric bioresorbable scaffold and everolimus-eluting cobalt chromium metallic stent in human coronary arteries: sequential assessment with optical coherence tomography in ABSORB Japan trial.
    Sotomi Y; Onuma Y; Dijkstra J; Miyazaki Y; Kozuma K; Tanabe K; Popma JJ; de Winter RJ; Serruys PW; Kimura T
    Eur Heart J Cardiovasc Imaging; 2018 Jan; 19(1):59-66. PubMed ID: 28158421
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Very late bioresorbable vascular scaffold thrombosis due to late device recoil.
    Cortese B; Piraino D; Ielasi A; Steffenino G; Orrego PS
    Int J Cardiol; 2015; 189():132-3. PubMed ID: 25889443
    [No Abstract]   [Full Text] [Related]  

  • 12. Post-dilatation after implantation of bioresorbable everolimus- and novolimus-eluting scaffolds: an observational optical coherence tomography study of acute mechanical effects.
    Blachutzik F; Boeder N; Wiebe J; Mattesini A; Dörr O; Most A; Bauer T; Röther J; Tröbs M; Schlundt C; Achenbach S; Hamm CW; Nef HM
    Clin Res Cardiol; 2017 Apr; 106(4):271-279. PubMed ID: 27757522
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Edge Vascular Response After Resorption of the Everolimus-Eluting Bioresorbable Vascular Scaffold　- A 5-Year Serial Optical Coherence Tomography Study.
    Tateishi H; Suwannasom P; Sotomi Y; Nakatani S; Ishibashi Y; Tenekecioglu E; Abdelghani M; Cavalcante R; Zeng Y; Grundeken MJ; Albuquerque FN; Veldhof S; Onuma Y; Serruys PW;
    Circ J; 2016 Apr; 80(5):1131-41. PubMed ID: 26936236
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Real-World Bioresorbable Vascular Scaffold Experience Compared With Second-Generation Metallic Drug-Eluting Stents in Complex Coronary Lesions.
    Okamoto N; Ueda H; Yoshimura T; Chamaria S; Bhatheja S; Vengrenyuk Y; Rabiei S; Barrientos Y; Kapur V; Barman N; Sweeny J; Baber U; Mehran R; Sharma SK; Kini AS
    J Invasive Cardiol; 2018 Jul; 30(7):251-255. PubMed ID: 29656280
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phenomenon of elongated struts: is optical coherence tomography accurate enough to analyze scaffold area?
    Kharlamov AN
    Int J Cardiol; 2013 Oct; 168(4):4280-4. PubMed ID: 23701927
    [No Abstract]   [Full Text] [Related]  

  • 16. First serial assessment at 6 months and 2 years of the second generation of absorb everolimus-eluting bioresorbable vascular scaffold: a multi-imaging modality study.
    Ormiston JA; Serruys PW; Onuma Y; van Geuns RJ; de Bruyne B; Dudek D; Thuesen L; Smits PC; Chevalier B; McClean D; Koolen J; Windecker S; Whitbourn R; Meredith I; Dorange C; Veldhof S; Hebert KM; Rapoza R; Garcia-Garcia HM
    Circ Cardiovasc Interv; 2012 Oct; 5(5):620-32. PubMed ID: 23048057
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Percutaneous coronary intervention for acute myocardial infarction in a pediatric patient with coronary aneurysm and stenosis due to Kawasaki disease.
    Drossner DM; Chappell C; Rab T; Kim D
    Pediatr Cardiol; 2012 Jun; 33(5):811-3. PubMed ID: 22311571
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treading the risky ground of coronary bifurcation lesion revascularization, the "biodegradable strategy" may represent the lifeline.
    Piraino D; Buccheri D; Andolina G
    Int J Cardiol; 2016 Oct; 221():577-80. PubMed ID: 27420582
    [No Abstract]   [Full Text] [Related]  

  • 19. Coronary artery perforation at the level of two-overlapping bioresorbable vascular scaffolds: The importance of vessel sizing and scaffold thickness.
    Pichette M; Chevalier F; Généreux P
    Catheter Cardiovasc Interv; 2015 Oct; 86(4):686-91. PubMed ID: 26122768
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Optical coherence tomography imaging of everolimus-eluting bioresorbable vascular scaffold implanted into coronary vein graft at 3-month follow-up.
    Roleder T; Parma Z; Smolka G; Ochała A; Wojakowski W
    Eur Heart J; 2014 Sep; 35(33):2207. PubMed ID: 24722807
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.